<DOC>
	<DOCNO>NCT00000938</DOCNO>
	<brief_summary>Lyme disease common tick-borne disease United States . It cause spirochete Borrelia burgdorferi . It may exist chronic form result : 1 ) persistent infection B. burgdorferi ; 2 ) damage cause original infectious process ; 3 ) presence coinfection another organism transmit Ixodes tick . The purpose study determine safety effectiveness , seronegative patient , intensive antibiotic treatment eliminate symptom Chronic Lyme Disease ( CLD ) .</brief_summary>
	<brief_title>A Randomized , Double-Blind , Placebo-Controlled , Multicenter Trial Safety Efficacy Ceftriaxone Doxycycline Treatment Patients With Seronegative Chronic Lyme Disease</brief_title>
	<detailed_description>Sixty-six patient enrol study . Each patient assign one two group randomly select receive either antibiotic therapy placebo ; , assignment medication make know patient administer doctor . Antibiotic placebo give intravenously ( IV ) 30 consecutive day orally next 60 consecutive day .</detailed_description>
	<mesh_term>Lyme Disease</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>You may eligible study : Are least 18 year age . Are seronegative antibody B. burgdorferi antigens Western Blot enrollment . Have document history acute Lyme disease . Have rash ( erythema migrans ) resemble bullseye . This skin aberration usually occur tick bite late spring , summer , early fall sometimes accompanied fatigue , fever , headache , mild stiff neck , arthralgia myalgia . Have one clinical feature typical Lyme disease acquire United States ( see technical summary ) Have one follow symptom condition persist least 6 month ( less 12 year ) attributable another cause condition : ) widespread musculoskeletal pain fatigue begin coincident within 6 month follow initial infection B. burgdorferi . b ) certain neurologic symptom include memory impairment nerve pain , begin within 6 month follow initial infection B. burgdorferi . Have physiciandocumented history prior antibiotic treatment currently recommend antibiotic regimen . You eligible study : Have previously enrol study . Are pregnant , lactating , unable use birth control measure treatment period study . Are take chronic medication could interfere evaluation symptom . Are take take various medication could interfere evaluation symptom ( see technical summary ) . Are hypersensitive ceftriaxone doxycycline . Have active inflammatory synovitis . Have another disease could account symptom acute Lyme disease . Have another serious active infection . Are unable tolerate IV . Have test positive Borrelia DNA plasma cerebrospinal fluid time initial evaluation study . Have test seropositive Western Blot ( patient may offer enrollment seropositive study ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2005</verification_date>
</DOC>